Fact-checked by Grok 2 weeks ago

Vaccinium myrtillus

Vaccinium myrtillus L., commonly known as , , or European blueberry, is a low-growing, in the family , characterized by slender branches arising from extensive rhizomes, reaching heights of 10–50 cm, with bright green ovate leaves, urn-shaped pinkish-white to reddish flowers, and globular dark blue to black berries covered in a waxy bloom. Native to circumboreal regions, V. myrtillus thrives in acidic, moist soils of coniferous forests, heaths, moors, bogs, and montane to zones, often forming dense colonies that contribute to and vegetation in ecosystems. Its distribution spans , , and , from and across temperate to and the (including , , and states like , , , and ), with disjunct populations in the extending south to and . Ecologically, V. myrtillus plays a vital role as a food source for wildlife, including birds such as and thrushes, and mammals like black bears, deer, and small , while its berries and foliage support pollinators and serve as browse for larger herbivores. The plant's berries are rich in anthocyanins, , and vitamins, contributing to its traditional and modern uses in products like jams, juices, and wines, as well as in for purported benefits in eye health, circulation, and support, though clinical varies. Taxonomically, V. myrtillus belongs to section Myrtillus within the genus , which comprises about 500 species of and small trees, and is classified as follows: Kingdom Plantae, Phylum Tracheophyta, Class Magnoliopsida, Order , Family , Genus Vaccinium. It is distinguished from similar North American species like V. membranaceum by its more prostrate growth and bluish berries with a distinct profile.

Taxonomy and Nomenclature

Taxonomic Classification

Vaccinium myrtillus belongs to the kingdom Plantae, phylum Tracheophyta, class Magnoliopsida, order , family , genus , and species V. myrtillus. This classification places it within the diverse family, which includes other ericoid shrubs adapted to acidic soils. The species authority is attributed to , who formally described it in his 1753 work . Within the genus , V. myrtillus is classified in section Myrtillus, a group characterized by low-growing, shrubs with urceolate corollas and berries borne singly. This section distinguishes V. myrtillus from other subgenera, such as subgenus Cyanococcus, which encompasses taller, more upright species like the highbush (V. corymbosum) used in commercial cultivation and featuring racemose inflorescences. Historical synonyms include the homotypic name Vitis-idaea myrtillus (L.) Moench from 1794, reflecting early taxonomic reassignments before stabilization under . Close relatives include V. uliginosum (bog bilberry), which shares section Myrtillus and similar deciduous habits, and V. vitis-idaea (lingonberry) from section Vitis-idaea, noted for evergreen leaves. Genetic studies highlight similarities among these species within the broader clade, particularly in population structure and diversity across shared northern habitats.

Etymology and Common Names

The scientific name Vaccinium myrtillus derives from roots. The genus name refers to a berry-bearing plant, possibly the bilberry itself or a related like , and is likely derived from bacca, meaning "berry," with historical usage in for similar plants. The specific myrtillus is a form of myrtus (), highlighting the plant's small leaves and berries that resemble those of the myrtle shrub; this was formalized by in his in 1753. Common names for Vaccinium myrtillus vary regionally, reflecting linguistic and cultural differences across its native range. In English-speaking areas, it is primarily known as , a term originating from the Danish bollebar or bølle, denoting a "dark " or "." Regional variants include blaeberry in and , derived from blā (blue or blue-black) combined with , emphasizing the fruit's dark hue; , wimberry, and whinberry in southwestern , with tracing to hurtilbery via Danish bølle for the type. In , it is called myrtille in , Heidelbeere in German (sometimes distinguished from the larger but often used interchangeably for wild blueberries), and borówka czarna (black ) in .

Description

Morphology

Vaccinium myrtillus is a low-growing, typically reaching heights of 10–60 cm, characterized by slender, branching stems that arise from extensive underground rhizomes, forming dense mats or open colonies. The exhibits a spreading habit, with stems that are green to reddish-brown, sharply angled, and either glabrous or slightly puberulent, often tinged orange-red in . These stems support the overall structure, with maximum aerial shoot ages reaching 15–18 years. The leaves are small, , and alternate, oval to elliptical in shape, measuring 1–3 cm in length and 0.5–2 cm in width, with finely serrated margins, an to obtuse , and a rounded to cuneate base. They are bright green during the and turn shades of red, yellow, or brown in autumn. Flowers emerge singly or in pairs from the axils of new leaves on short pedicels; they are small, - or bell-shaped (urceolate to campanulate), pinkish-white to reddish, 4–6 mm long, and pendulous, blooming from to July depending on location. is primarily achieved by , such as bumblebees, which are effective in transferring for set. The fruit is a spherical , 5–10 mm in diameter, dark blue to black with a waxy, bloom coating the surface; the flesh is purple-pigmented and contains numerous small nutlet-like (up to about 70 per ). Berries ripen 50–70 days after flowering, typically from to . As a chamaephyte, V. myrtillus exhibits rhizomatous growth, with new shoots emerging in (March–April) and active growth lasting about 5 months before winter . Reproduction occurs vegetatively through rhizome extension and budding, forming clonal networks that can persist for decades (rhizomes up to 34 years old), alongside via insect-pollinated that germinate under suitable conditions.

Chemical Composition

The fruits of Vaccinium myrtillus are particularly rich in , which serve as the primary pigments responsible for their characteristic blue color and contribute to their properties. These compounds typically constitute 300–700 mg per 100 g of fresh fruit, with the main types including glycosides of , , and malvidin, such as , , , and malvidin-3-O-galactoside. On a dry weight basis, total content can range from 1,971 to 3,803 mg per 100 g, varying by population and environmental factors. represent the largest fraction of the content in the fruits. Other phenolic compounds in V. myrtillus fruits include such as (approximately 3 mg per 100 g fresh weight) and catechins (around 20 mg per 100 g fresh weight), as well as phenolic acids like . The leaves, in contrast, contain higher levels of , ranging from 0.8% to 6.7% of dry weight, and (hydroquinone β-D-glucopyranoside), with contents varying from 1,000 to 2,400 mg per 100 g dry weight. These differences highlight the fruit's emphasis on anthocyanin-rich pigmentation and the leaves' prominence in and related phenolics. In addition to phenolics, V. myrtillus fruits provide notable vitamins and minerals. content is approximately 12–15 mg per 100 g fresh weight, while is present in smaller amounts. The fruits are also a source of , with levels up to approximately 30 mg per kg fresh weight—which is substantially higher than in cultivated blueberries (around 3.4 mg per kg)—and , at about 3.0–3.5 g per 100 g fresh weight. Volatile compounds contribute to the aroma of V. myrtillus fruits, with key examples including the linalool, , and 1,8-cineole, alongside other monoterpenes that form a complex profile detected via headspace analysis.

Distribution and Ecology

Geographic Distribution

Vaccinium myrtillus exhibits a Holarctic native distribution, spanning the northern , , and . In , it is widespread from the and westward through , where it extends north to approximately 70°N, to and the , as well as central and southern mountainous areas including the , , and Carpathians. In , the species ranges from and the , including regions like and Yakutiya, eastward to , , , and parts of northern such as . In , it occurs natively from and southward through the to central , northern , and . Populations in southwestern are also native, likely originating from stock via historical dispersal. The species' historical spread is tied to post-glacial following the , with rapid colonization of deglaciated landscapes through by birds and mammals, establishing dominance in boreal forest understories across its range. This circumboreal pattern reflects adaptation to temperate and climates, with evidence indicating expansion into northern latitudes as ice sheets retreated around 10,000–15,000 years ago. Introduced ranges are limited, primarily involving cultivation for berry production in temperate parts of and outside its native core, such as experimental plantings in the and central lowlands; it has naturalized sporadically in some disturbed temperate habitats but does not form extensive invasive populations. Currently, V. myrtillus covers vast areas within its native range, estimated at several million square kilometers in boreal zones alone, with populations generally stable yet occurring in patchy distributions influenced by and soil conditions.

Habitat and Growth Requirements

Vaccinium myrtillus thrives in a variety of acidic, nutrient-poor environments across temperate and regions, including , heaths, coniferous forests, bogs, and meadows. These habitats typically feature moderate shade levels, with optimal growth occurring under 30-70% canopy cover, where partial shading from overstory trees supports its dominance without excessive competition for light. The plant requires well-drained, humus-rich soils that are sandy or loamy in texture, with a range of 4.0 to 5.5 to prevent and promote root health. It favors cool, humid climates characteristic of zones, with annual rainfall typically between 500 and 1000 mm to maintain without waterlogging. Vaccinium myrtillus exhibits strong frost tolerance, surviving temperatures as low as -30°C, which enables its persistence in regions with harsh winters. Ecologically, Vaccinium myrtillus plays a key role as a dominant understory species in boreal forests, contributing to ground cover and biodiversity. It forms symbiotic ericoid mycorrhizal associations with fungi such as Oidiodendron maius and Rhizoscyphus ericae, which enhance nutrient uptake, particularly nitrogen and phosphorus, in nutrient-poor soils. The plant interacts with herbivores like deer, rodents, and bears, which consume its foliage and berries, while pollinators including bees facilitate its reproduction through cross-pollination of its flowers. Growth in Vaccinium myrtillus is characteristically slow, with annual height increments of 5-10 cm, reflecting its to stable, low-resource environments. In optimal light conditions within its preferred range, it achieves high yields, up to 1 kg per square meter in productive years, supporting its ecological and economic value.

Cultivation and Conservation

Cultivation Methods

Vaccinium myrtillus is propagated primarily through , semi-hardwood cuttings, or techniques for enhanced conservation efforts. propagation involves extracting from ripe berries collected in late summer, followed by cold at 4°C for approximately 90 days to break , after which they are surface-sown in a moist, acidic medium under conditions for . Semi-hardwood cuttings, taken in summer from current-season growth (8-12 cm long), are treated with 2000 ppm (IBA) and rooted in a 50:50 perlite-peat mix under mist with bottom heat at 21°C, achieving about 48% rooting success in 14 weeks. via uses nodal explants on supplemented with cytokinins like N6-isopentenyladenine, enabling rapid multiplication and rooting rates up to 71.9% with potassium indolebutyrate, particularly useful for preserving . Site preparation for requires acidic, well-drained loamy or sandy soils with a of 4.0-5.5, achieved by amending neutral or alkaline soils with peat moss, pine needles, or elemental several months in advance. thrive in partial shade mimicking conditions, with spacing of 30-50 cm between shrubs to allow for their spreading habit up to 1 m wide. Raised beds or containers filled with ericaceous are recommended for poor sites to prevent waterlogging. Ongoing care includes mulching with pine bark or leaf mold in spring to retain moisture and suppress weeds, while maintaining consistent using rainwater to avoid tap water's higher . Fertilization should be minimal and low in nitrogen, such as or ericaceous formulations applied sparingly in spring (e.g., 13-13-13 Osmocote at 1 g per container), to prevent excessive vegetative growth. in late winter involves removing dead and thinning crowded stems to promote airflow and fruiting on 2-3-year-old . Harvest occurs from to when berries turn deep blue and detach easily, ideally using hand-picking or combs for larger plantings. Challenges in cultivation include high susceptibility to root rot from species in alkaline or waterlogged soils, necessitating strict and management. Commercial remains limited, with most berries wild-harvested, though potential expansion exists in through managed forest clearings and fertilization to boost yields. Mature plants (3-5 years old) typically yield 0.5-2 kg of fruit per under optimal conditions, far below highbush blueberries but valuable for niche markets.

Conservation Status

Vaccinium myrtillus is assessed as Least Concern on the (as of ), indicating a low risk of extinction globally due to its widespread distribution across the Holarctic region and large population sizes. Similarly, NatureServe ranks it as Secure (G5), reflecting its abundance in native ranges, particularly in boreal forests of and . Despite this overall stability, local populations face threats that could impact regional viability if not managed. Regional threats include habitat loss from intensive forestry practices, such as clear-cutting, which negatively affects cover and berry production in boreal ecosystems. In , particularly and , commercial and recreational harvesting exerts pressure on populations, with annual wild yields estimated at 200-300 million kg across the region, though actual harvested amounts are lower at around 20-30 million kg combined, representing a sustainable fraction but potentially unsustainable locally with unregulated picking. Fires and overcollection have led to drastic reductions in abundance in specific areas, such as the Tropoja region in , where habitat degradation compounds these issues. poses an additional risk, with warming temperatures causing upward shifts in alpine ranges and potential declines in subalpine populations due to altered , increased mortality, and niche in some habitats; however, recent studies indicate in certain subalpine belts due to reduced and warming. Conservation measures focus on protecting wild populations through integration into broader habitat directives, including the EU Habitats Directive, which safeguards associated woodlands and heaths where V. myrtillus is a key species. Sustainable harvesting is promoted via guidelines and quotas in to prevent overexploitation, alongside research into propagation for germplasm banks to preserve . Reintroduction efforts in degraded sites, such as those in Tropoja, , aim to restore local populations through propagation and habitat rehabilitation. Overall population trends remain stable, with high observed in northern European populations supporting resilience, though declines are noted in certain subalpine areas vulnerable to warming.

Uses

Culinary Applications

The fruits of Vaccinium myrtillus, commonly known as bilberries, are widely used in culinary preparations due to their tart-sweet flavor and vibrant color. They are consumed fresh, often in Nordic countries where they are paired with cream or incorporated into porridges for a simple dessert. Processed forms include jams, pies, juices, and liqueurs; for instance, traditional Swedish liqueurs draw from wild bilberry harvests to create flavored spirits enjoyed as after-dinner drinks. Dried bilberries are steeped to make herbal teas, providing a mild, fruity infusion suitable for everyday consumption. Bilberries offer a low-calorie profile, with approximately 57 kcal per 100 g, and are notably high in , contributing to their appeal in health-conscious diets. Their rich content imparts properties, enhancing the of dishes while adding a hue to baked goods like muffins and sauces. In , bilberries feature prominently in porridges and baked treats, where their natural pigments intensify flavors without added sugars. Freezing bilberries effectively preserves their color and texture, allowing year-round use in recipes by preventing anthocyanin degradation during storage. Commercially, products like bilberry syrup are popular in , often diluted for beverages or drizzled over desserts. Historically, indigenous groups such as the foraged bilberries for winter storage, drying or cooking them into stews and breads to sustain communities through harsh seasons. Today, Europe's wild bilberry market yields around 5,000 tons annually, primarily through in and regions, supporting both local and export demands.

Medicinal Applications

Vaccinium myrtillus, commonly known as , has been employed in traditional since , primarily using its to address gastrointestinal and urinary ailments. The dried was traditionally prepared as a tea to treat nonspecific and , leveraging its properties for symptomatic relief. Additionally, has a long history of use for urinary tract issues, such as infections and , often consumed as an or juice. In the context of vision health, a notable piece of folklore emerged during , when British pilots reportedly consumed jam before night flights, believing it enhanced their capabilities, a tradition rooted in earlier herbal practices for eye disorders like cataracts and . Teas made from the were also used to soothe in the mouth and throat. The leaves of Vaccinium myrtillus have been utilized in folk medicine, particularly for managing and related conditions. Decoctions of the leaves were traditionally administered to help control blood sugar levels, a practice dating back to the late and predating the discovery of insulin, with widespread use in herbalism for ameliorating diabetic symptoms. These preparations were also applied topically as rinses or gargles for mouth and infections, as well as for , including ulcers. In Northern traditions, such as those in , bilberry leaves served as a digestive aid, often in the form of infusions to alleviate upset and . In cultural contexts, bilberry holds significance in Sami and Finnish folk medicine as a remedy for digestive disorders, reflecting its role in indigenous practices for gastrointestinal support. Today, these traditional uses have influenced modern herbal supplements, which often feature standardized extracts of the fruit rich in anthocyanins, the plant's key bioactive compounds. Common dosage forms in traditional applications include infusions of 1-2 g of dried leaves per day, steeped in 150 mL of boiling water for 5-10 minutes, and fruit extracts standardized to provide 100-200 mg of anthocyanins daily. Dried fruit was typically used at 20-60 g per day in teas or preserves.

Pharmacology and Safety

Pharmacological Effects

Vaccinium myrtillus, commonly known as , contains anthocyanins that contribute to its pharmacological effects, primarily through and mechanisms observed in preclinical and clinical studies. These compounds scavenge free radicals, inhibit , and modulate pathways, as demonstrated in liver microsomes where extract reduced and activity. Clinical trials have shown reductions in inflammatory markers such as high-sensitivity (hsCRP) and interleukin-6 (IL-6) following supplementation with 330 mL juice daily for 4 weeks in adults at cardiovascular risk. Similarly, 400 g of fresh daily for 8 weeks lowered hsCRP and IL-6 levels in individuals with , supporting improved endothelial function via pathways. In ocular health, extracts improve and show mild benefits for conditions like and dry eyes, based on limited clinical . A double-blind with 160 mg extract twice daily for 1 month reported 77-90% improvement in symptoms of diabetic and , attributed to enhanced retinal blood flow. For dry eyes, supplementation with 160 mg extract daily for 30 days improved the Ocular Surface Index score in patients compared to . However, meta-analyses and reviews indicate only small improvements overall, with no robust for preventing or treating progression beyond short-term symptom relief. Regarding vision enhancement, randomized -controlled trials, such as one involving 160 mg extract (25% anthocyanosides) three times daily for 21 days, found no improvement in night or contrast sensitivity in healthy young adults. Metabolic effects include potential blood glucose lowering through alpha-glucosidase inhibition and modulation in preclinical models, with mixed clinical outcomes. A 2025 meta-analysis of randomized controlled trials reported a marginal reduction in HbA1c (weighted mean difference: -1.63%, p=0.06) but no significant change in blood glucose following supplementation. The same , encompassing 8 RCTs with 409 participants, found no significant overall effects on , including a non-significant decrease in total (WMD: -0.11 mmol/L, p=0.27) and triglycerides (WMD: -0.07 mmol/L, p=0.62), no change in HDL (WMD: -0.02 mmol/L, p=0.70), but a small significant increase in LDL (WMD: 0.07 mmol/L, p=0.01); earlier individual studies reported decreases in LDL and increases in HDL in specific populations such as those with . Preclinical studies further support hypoglycemic action, with extract reducing plasma glucose by 26% in diabetic rats. Additional effects encompass anticarcinogenic potential and cardiovascular protection, primarily from in vitro and animal data. Bilberry powder at 10-25 mg/mL inhibited oral carcinoma cell proliferation, migration, and invasion in HSC-3 cells, with reduced tumor area in zebrafish models. For cardiovascular health, extracts at 100 mg/kg reduced ischemia-reperfusion injury and leukocyte adhesion in hamsters, while human trials with 320 mg anthocyanins daily improved flow-mediated dilation. The European Medicines Agency's 2015 assessment recognizes bilberry for traditional use in minor venous circulatory disturbances at doses of 80-180 mg extract (providing 60-160 mg anthocyanins) daily, though large-scale clinical trials are needed to confirm broader efficacy. A 2025 systematic review and meta-analysis confirmed reductions in some inflammatory markers but emphasized the need for more high-quality studies on cardiometabolic indices.

Toxicity Profile

Vaccinium myrtillus fruit is (GRAS) for consumption in amounts typically found in foods, with no significant reported at these levels. In contrast, the leaves contain high concentrations of , which can lead to adverse effects such as or when consumed in high doses exceeding 10 g per day or over extended periods. leaf extracts are considered possibly unsafe in such scenarios due to these tannin-related risks. Acute toxicity studies indicate low risk, with no lethal effects observed in at oral doses exceeding 2000 mg/kg body weight, suggesting an LD50 value well above this threshold. assessments in animal models, including rats and dogs over periods up to 6 months, showed no significant adverse outcomes at doses up to 500 mg/kg, though minor changes like darkened urine or stool were noted. There is no evidence of for the fruit, while leaves exhibit weak mutagenic potential ; no carcinogenicity data are available, but no such risks have been identified in available studies. Rare allergic reactions, including , swelling, or difficulty breathing, may occur, particularly in individuals sensitive to or related berries. Bilberry may interact with antidiabetic medications by enhancing their blood sugar-lowering effects, potentially leading to , so is advised in diabetic patients. It has also been associated with increased bleeding risk when combined with anticoagulants like , based on case reports of elevated INR levels, though this interaction is not consistently confirmed at standard doses. The () reports no major safety concerns for preparations used traditionally, approving them for short-term oral or oromucosal use, while recommending leaves be limited to short-term application due to insufficient long-term data. For vulnerable groups, is likely safe during at food levels, but supplements are not recommended due to limited data; leaves should be avoided in and . Use in children under 2 years is contraindicated, with caution advised for those under 12, particularly for leaf preparations. Diabetics should monitor blood sugar closely when using any products.